1. Home
  2. LGIH vs DVAX Comparison

LGIH vs DVAX Comparison

Compare LGIH & DVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGIH
  • DVAX
  • Stock Information
  • Founded
  • LGIH 2003
  • DVAX 1996
  • Country
  • LGIH United States
  • DVAX United States
  • Employees
  • LGIH N/A
  • DVAX N/A
  • Industry
  • LGIH Homebuilding
  • DVAX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LGIH Consumer Discretionary
  • DVAX Health Care
  • Exchange
  • LGIH Nasdaq
  • DVAX Nasdaq
  • Market Cap
  • LGIH 1.2B
  • DVAX 1.3B
  • IPO Year
  • LGIH 2013
  • DVAX 2004
  • Fundamental
  • Price
  • LGIH $64.17
  • DVAX $10.65
  • Analyst Decision
  • LGIH Hold
  • DVAX Buy
  • Analyst Count
  • LGIH 5
  • DVAX 4
  • Target Price
  • LGIH $67.75
  • DVAX $26.50
  • AVG Volume (30 Days)
  • LGIH 413.5K
  • DVAX 1.4M
  • Earning Date
  • LGIH 08-05-2025
  • DVAX 08-07-2025
  • Dividend Yield
  • LGIH N/A
  • DVAX N/A
  • EPS Growth
  • LGIH N/A
  • DVAX N/A
  • EPS
  • LGIH 6.64
  • DVAX N/A
  • Revenue
  • LGIH $2,044,155,000.00
  • DVAX $316,268,000.00
  • Revenue This Year
  • LGIH N/A
  • DVAX $21.18
  • Revenue Next Year
  • LGIH $27.62
  • DVAX $16.83
  • P/E Ratio
  • LGIH $9.58
  • DVAX N/A
  • Revenue Growth
  • LGIH N/A
  • DVAX 26.66
  • 52 Week Low
  • LGIH $47.17
  • DVAX $9.22
  • 52 Week High
  • LGIH $125.83
  • DVAX $14.63
  • Technical
  • Relative Strength Index (RSI)
  • LGIH 63.81
  • DVAX 44.22
  • Support Level
  • LGIH $55.41
  • DVAX $9.86
  • Resistance Level
  • LGIH $67.50
  • DVAX $12.06
  • Average True Range (ATR)
  • LGIH 2.92
  • DVAX 0.45
  • MACD
  • LGIH 0.85
  • DVAX -0.09
  • Stochastic Oscillator
  • LGIH 77.67
  • DVAX 28.41

About LGIH LGI Homes Inc.

LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. They have seven operating segments ( West, Northwest, Central, Midwest, Florida, Southeast and Mid-Atlantic) that it aggregates into five qualifying reportable segment. Majority of the revenue is generated from Central division segment.

About DVAX Dynavax Technologies Corporation

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

Share on Social Networks: